Monosodium luminol upregulates the expression of Bcl-2 and VEGF in retrovirus-infected mice through downregulation of corresponding miRNAs

Acta Virologica

Volumn 54, Issue 1, 2010, Pages 27-32

  Lungu, G ^a   Kuang, X ^b   Stoica, G ^a   Wong, P K Y ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Bcl 2; miRNAs; Monosodium luminol; ts1 virus; VEGF

Indexed keywords

ANTIOXIDANT; LUMINOL; LUMINOL MONOSODIUM; MESSENGER RNA; MICRORNA; MICRORNA 15; MICRORNA 16; PHTHALAZINE DERIVATIVE; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASCULOTROPIN; BCL2 PROTEIN, MOUSE; ONCOPROTEIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; MICROARRAY ANALYSIS; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NERVE DEGENERATION; NONHUMAN; PROTEIN EXPRESSION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS MUTANT; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOGENICITY; TREATMENT OUTCOME; UPREGULATION; VIROLOGY;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MUS;

ANIMALS; BRAIN STEM; DOWN-REGULATION; HUMANS; LUMINOL; MICE; MICRORNAS; MOLONEY MURINE LEUKEMIA VIRUS; MUTATION; NERVE DEGENERATION; PROTO-ONCOGENE PROTEINS; TREATMENT OUTCOME; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77952297466     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2010_01_27     Document Type: Article

References (38)

1. Allsopp TE, Wyatt S, Paterson HF, Davies AM. (1993) The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73, 295-307.
2. Bartel DP. (2004) MicroRNAs genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. Bushati N, Cohen MS. (2008) MicroRNA in neurodegeneration. Curr. Opin. Neurobiol. 18, 292-296.
4. Chable-Bessia C, Meziane O, Latreille D, Robinson RT, Zamborlini A, Wagschal A, Jacwuet JM, Reynes J, Levy Y, Saib A, Bennasser Y, Benkiran M. (2009) Suppression of HIV-1 replication by microRNA effectors. Retrovirology 9, 6-26.
5. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. (2005) miR-15 and miR-16 induce apoptosis by targeting BCL-2. PNAS 39, 102-110.
6. Clark S, Duggan J, Chakraborty J. (2001) Ts1 and LP-BM5 a comparison of two murine retrovirus models for HIV. Viral Immunol. 14, 95-109.
7. Davies AM. (1995) The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci. 18, 355-358.
8. Ding SW, Voinnet O. (2007) Antiviral immunity directed by small RNAs. Cell 10, 413-426.
9. Fillipowicz W, Bhattacharyya SN, Sonenberg N. (2008) Mechanisms of post-transcriptional regulation by microRNAs are the answers in sight? Nat. Rev. Genet. 9, 102-114.
10. Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, Ponzoni M, Naldini L. (2008) Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6, 63-66.
11. Ghosh Z, Mallick B, Chakrabarti J. (2008) Cellular versus viral microRNA in host-virus interaction. Nucleic Acids Res. 1-14.
12. Gonzales-Scarano, Nathanson N, Wong PKY. (1995) Retroviruses and the nervous system. The Retroviridea 4, 409-490.
13. Gottwein E, Cullen BR. (2008) Viral and cellular microRNAs a sdeterminant of viral pathogenesis and immunity. Cell Host Microbe 12, 375-387.
14. Han Y, Siliciano RF. (2007) Keeping quiet microRNAs in HIV-1 latency. Nat. Med. 13, 1138-1140.
15. Hua Z, Qiang LV, Wenbin Y, Wong ACK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y. (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLos ONE 1, 116-121.
16. Jiang Y, Scofield VL, Yan M, Qiang W, Liu N, Reid AJ, Lynn WS, Wong PKY. (2006) Retrovirus-induced oxidative stress with neuroimmunodegeneration is suppressed by antioxidant treatment with a refined monosodium α-luminol (Galavit). J. Virol. 80, 4557-4567.
17. Jolicoeur P, Hu C, Mak TW, Martinou JC, Kay DG. (2003) Protection against Murine Leukemia Virus-Induced Spongiform Myeloencephalopathy in Mice Overexpressing Bcl-2 but Not in Mice Deficient for Interleukin-6, Inducible Nitric Oxide Synthetase, ICE, Fas, Fas Ligand, or TNF-R1 Genes. J. Virol. 77, 13161-13170.
18. Kim HT, Tasca S, Qiang W, Wong PKY, Stoica G. (2002) Induction of p53 accumulation by molony murine leukemia viruts1 infection in astrocyets via activation of extracellular signal-regulated kinases 1/2. Lab. Investig. 82, 693.
19. Lacellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O. (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308, 557-560.
20. Liu Z, Sall A, Yang D. (2008) MicroRNA an emerging therapeutic target and intervention tool. Int. J. Mol. Sci. 9, 978-999.
21. Lungu G, Stoica G, Wong PKY. (2008) Down-regulation of Jab1, HIF-1α, and VEGF by Molony Murine Leukemia Virus-ts1 infection; A possible cause of neurodegeneration". J. Neurovirol. 14, 239-215.
22. Mendes O, Kim HT, Stoica G. (2005) Expression of MMP-2, MMP-9 and MMP-3 in breast cancer brain metastasis in a rat model. Clin. Exp. Metastasis 22, 237-246.
23. Prasad G, Stoica G, Wong PKY. (1989) The role of thymus in the pathogenesis of hind-limb paralysis induced by ts1, a mutant of Molony murine leukemia virus-TB. Virology 169, 332-340.
24. Qiang W, Kuang X, Liu J, Liu N, Scofield VL, Reid AJ, Jiang Y, Stoica G, Lynn WS, Wong PKY. (2006) Astrocytes survive chronic infection and cytopathic effects of the ts1 mutant of the retrovirus moloney murine leukemia virus by upregulation of antioxidant defenses. J. Virol. 3273-3284.
25. Scofield VL, Yan M, Kuang X, Kim SJ, Crunk D, Wong PKY. (2009a) The drug monosodium luminol (GVT) preserves thymic epithelial cell cytoarchitecture and allows thymocyte survival in mice infected with the T cell-tropic, cytopathic retrovirus ts1. Immunol. Lett. (in press).
26. Scofield VL, Yan M, Kuang X, Kim SJ, Wong PKY. (2009b) The drug monosodium luminol (GVT) preserves crypt-villus epithelial cell organization and allows survival of intestinal T cells in mice infected with the ts1 retrovirus. Immunol. Lett. (in press).
27. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, Goldman-Wohl D, Greenfield C, Yagel S, Hengel H, Altuvia Y, Margalit H, Mandelboim O. (2007) Host immune system gene targeting by a viral miRNA. Science 317, 376-81.
28. Stoica G, Illanes O, Tasca SI, Wong PKY. (1993) Temporal central and peripheral nervous system changes induced by a paralytogenic mutant of Moloney murine leukemia virus TB. Lab. Invest. 69, 724-735.
29. Stoica G, Tasca SI, Wong PKY. (2000) Motor neuronal loss and neurofilament-ubiquitin alteration in MoMuLVts1 encephalopathy. Acta Neuropathol. 99, 238-244.
30. Storkebaum E, Lambrechts D, Carmeliet P. (2004) VEGF once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bio Essays 26, 943-954.
31. Szurek PF, Yuen PH, Ball JK, Wong PK. (1990) A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB. J. Virol. 64, 467-475.
32. Wong PKY, Soong MM, Yuen PH. (1981) Replication of leukemia virus in heterologous cells Interaction between ecotropic and xenotropic viruses. Virology 109, 366-378.
33. Wong PKY, Knupp C, Yuen PH, Soong MM, Zachary JF, Tompkins WAF. (1985) ts1, a paralytogenic mutant of Moloney murine leukemia virus TB, has an enhanced ability to replicate in the central nervous system and primary nerve cell culture. J. Virol. 55, 760-767.
34. Wong PKY, Prasad G, Hansen J, Yuen PH. (1989) ts1, a mutant of Moloney murine leukemia virus-TB, causes both immunodeficiency and neurologic disorders in BALB/c mice. Virology 170, 450-459.
35. Wong PKY, Floyd E, Szurek PF. (1991) High susceptibility of FVB/N mice to the paralytic disease induced by ts1, a mutant of Moloney murine leukemia virus TB. Virology 180, 365-371.
36. Yeung ML, Bennasser Y, Le SY, Jeang KT. (2005) siRNA, mRNA and HIV promises and challenges. Cell. Res. 15, 935-946.
37. Yeung ML, Benkirane M, Jeang KT. (2007) Small non-coding RNAs, mammlian cells, and viruses. Retrovirology 15, 4-47.
38. Yuen PH, Szurek P. (2008) The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV-TB is mapped to 11 mutations within the U3 region of the long terminal repeat. J. Virol. 63, 471-480.